Innovating Works

FUNDACION PARA LA INVESTIGACION BIOMEDIC...

Activa
SECURED: Scaling Up secure Processing, Anonymization and generation of Health Data for EU cross border collab... FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un HORIZON EUROPE HORIZON-HLTH-2022-IND-13 The overall goal of the SECURED project is to scale up multiparty computation, data anonymization and synthetic data generation, by increasi...
2022-11-23 - 2025-12-31 | Financiado
BIOMATDB: Advanced Database for Biomaterials with Data Analysis and Visualisation Tools extended by a Marketpl... FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un HORIZON EUROPE HORIZON-CL4-2021-RESILIENCE-01 Biomaterials in healthcare span almost all medical fields, ranging from recognised materials to high-innovative smart and multi-functional b...
2022-05-23 - 2024-11-30 | Financiado
BEAMER: BEhavioral and Adherence Model for improving quality health outcomes and cost Effectiveness of heal... FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un H2020 H2020-JTI-IMI2-2020-23-two-stage The main objective of the Project is to create BEAMER, a disease-agnostic behavioral and adherence model for improving quality, health outco...
2021-09-27 - 2026-08-31 | Financiado
iProcureSecurity: Strategic Partnership of Emergency Medical Service Practitioners for Coordination of Innovation Proc... FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un H2020 H2020-SU-DS-2018-2019-2020 Emergency Medical Services in Europe are characterised by a pluralistic landscape with diverse organisational setups, professional standards...
2019-04-26 - 2020-12-31 | Financiado
DEFeND: Data Governance for Supporting GDPR FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un H2020 H2020-DS-2016-2017 The rapid advances in ICT have raised the need to adapt to this progress for organisations (pushing them towards e-services and increase the...
2018-04-23 - 2021-03-31 | Financiado
GENEGRAFT: Phase I II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using... FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESUS participó en un FP7 RDEB is one of the most severe rare genetic skin diseases of children and adults characterized by skin blistering resulting from lack of ex...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.